Subscribe to RSS
DOI: 10.1055/s-2004-814395
Stadiengerechte Chirurgie von Saccus-endolymphaticus-Tumoren (ELST)
Tumour Staged Surgery of Endolymphatic Sac Tumors (ELST)Publication History
Eingegangen: 8. Januar 2004
Angenommen: 6. Februar 2004
Publication Date:
18 August 2004 (online)
Zusammenfassung
Hintergrund: Saccus-endolymphaticus-Tumore (ELST) sind erst seit 1984 als eine eigene Tumorentität bekannt. Der ELST kann sowohl sporadisch solitär als auch heriditär im Rahmen eines Von-Hippel-Lindau (VHL)-Syndroms auftreten. Dieser Zusammenhang wurde erstmals 1992 beobachtet und wurde durch weitere molekulargenetische Analysen des VHL-Gens schließlich bestätigt. Zur Diagnostik und Therapie gibt es bislang keine übereinstimmende Vorstellungen.
Methode: Wir haben aufgrund eigener Erfahrungen und Literaturdaten erstmals den Versuch unternommen, diese Form von Tumoren zu klassifizieren: ELST-Typ A lokal begrenzt ohne Knochenarrosion des Felsenbeins und Infiltration des Subarachnoidalraumes, ELST-Typ B mit knöcherner Infiltration des Labyrinthblocks und klinischem Hörverlust sowie ELST-Typ C mit zusätzlicher Infiltration des Sinus sigmoideus sowie des Bulbus venae jugularis. Die präoperative Diagnostik erfolgt anhand definierter radiologischer Kriterien im CT und MR einschließlich MR-Angiographie.
Ergebnis: Entsprechend der von uns entwickelten Tumorklassifikation wurde bei 6 Patienten, davon zwei Patienten im Rahmen eines VHL-Syndroms, ein ELST stadiengerecht von transmastoidal, translabyrinthär bis infratemporal chirurgisch komplett saniert. In allen Tumorstadien konnte der N.VII und im Stadium ELST-Typ A auch der N.VIII erhalten werden. Bei einer Nachbeobachtungszeit von 4 bis 38 Monaten waren alle Patienten im Kontroll-MR ohne Lokalrezidiv. Schlussfolgerungen: Die von uns erarbeitete stadiengerechte Chirurgie von ELST erlaubt eine komplette Tumorsanierung bei geringster Morbidität. Im Gegensatz zu den antero- und retrosigmoidalen sowie suboccipitalen Zugangswegen erlaubt der transmastoidale Zugangsweg eine sichere Entfernung der Tumormatrix zum Ausschluss eines Lokalrezidivs.
Abstract
Background: Endolymphatic sac tumours (ELST) have only been known as own tumour entities since 1984. ELST might occur solitarily and sporadically as well as hereditary connected to von Hippel-Lindau disease (VHL). This connection has been observed in 1992 for the first time and confirmed by molecular genetic analyses of the VHL gen. There is no agreement yet concerning diagnostics and therapy.
Methods: Our attempt of classifying this type of tumour is the first one. According to our own experience and to literature, we suggest the following classification: ELST type A is locally confined without erosions of the temporal bone nor infiltration of the subarachnoidal area; ELST type B with bony infiltration of the labyrinth block and clinical hearing loss, and ELST type C with additional infiltration of the sigmoid sinus and the vein of jugular bulb. Preoperative diagnostics are performed according to defined radiological criteria in CT and MRI scans including MR-angiography.
Results: In 6 patients, including two with a VHL syndrome, ELST was completely sanitized by stage-compatible surgery, using translabyrintine to infratemporal approaches, according to the tumour classification that we developed. The VIIth nerve could be saved in all tumour stages, and in stage ELST type A the VIIIth nerve as well. All patients remained without local recurrence in MRI check during the observation period of 4 to 38 months.
Conclusion: Our stage-compatible surgery of ELST allows total tumor removal with minor morbidity. In contrast to the antero-, retrosigmoidal and suboccipital approaches, the tumour matrix can be safely removed via transmastoidal approach to exclude local recurrences.
Schlüsselwörter
Von-Hippel-Lindau-Syndrom - Morbidität - Tumorklassifikation - operativer Zugangsweg - Tumormatrix
Key words
Von Hippel-Lindau disease - morbidity - tumour classification - surgical approach - tumour matrix
Literatur
- 1 Hassard A D, Bourdreau S F, Cron C C. Adenoma of the endolymphatic sac. J Otolaryngol. 1984; 13 213-216
- 2 Roncaroli F, Giangaspero F, Piana S, Andreoli A, Ricci R. Low grade adenocarcinoma of endolymphatic sac mimicking jugular paraganglioma at clinical and neuroradiological examination. Clin Neuropathol. 1997; 16 243-246
- 3 Eby T L, Makek M S, Fisch U. Adenomas of the temporal bone. Ann Otol Rhinol Laryngol. 1988; 97 605-612
- 4 Gaffey N J, Mills S E, Fechner R E, Intemann S R, Wick M R. Aggressive papillary middle ear tumour. A clinicopathologic entity distinct from middle ear adenoma. Am Surg Pathol. 1988; 12 790-797
- 5 Delisle M B, Uro E, Rouquette E, Yardeni E, Rumeau J L. Papillary neoplasm of the endolymphatic sac in a patient with von Hippel-Lindau disease. J Clin Pathol. 1994; 47 959-961
- 6 Harrison K, Cronin J, Greenwood N. Ceruminous adenocarcinoma in the middle ear. J Laryngol Otol. 1974; 88 363
- 7 Pollak A, Bohmer A, Spycher M, Fisch U. Are papillary adenomas endolymphatic sac tumours?. Ann Otol Rhinol Laryngol. 1995; 94 613-619
- 8 Ho V T, Rao V M, Doan H T, Mikaelian D O. Low grade adenocarcinoma of probable endolymphatic sac origin: CT and MR appearance. AJNR Am J Neuroradiol. 1996; 17 168-170
- 9 Folker R J, Meyerhoff W L, Rushing E J. Aggressive papillary adenoma of the cerebellopontine angle: case report of an endolymphatic sac tumor. Am J Otolaryngol. 1997; 18 135-139
- 10 Heffner D K. Low-grade adenocarcinoma of probable endolymphatic sac origin: a clinicopathologic study of 20 cases. Cancer. 1989; 64 2292-2302
- 11 Benecke J E, Noel F L, Carberry J N, House J W, Patterson M. Adenomatous tumours of the middle ear and mastoid. Am J Otol. 1990; 11 20-26
- 12 Li J C, Brackmann D E, Lo W WM, Carberry J N, House J W. Reclassication of aggressive adenomatous mastoid neoplasms as endolymphatic sac tumours. Laryngoscope. 1993; 103 1342-1348
- 13 Jones S EM, Yung M W, Orell J M, Norris A. Adenoma of the middle ear: a report of two cases. J Laryngol Otol. 2001; 115 216-219
- 14 Reijneveld J, Hanlo P, Groenewoud G, Jansen G, van Overbeeke K, Tulleken C. Endolymphatic sac tumours: A case report and review of the literature. Surg Neurol. 1997; 48 368-373
- 15 Roche P, Dufour H, Figarella-Branger D, Pellet W. Endolymphatic sac tumours: Report of three cases. Neurosurgery. 1998; 42 927-932
- 16 Ferreira M A, Feiz-Erfan I, Zabramski J M, Spetzler R F, Coons S W, Preul M C. Endolymphatic sac tumor: unique features of two cases and review of the literature. Acta Neurochir (Wien). 2002; 144 1047-1053
- 17 Kempermann G, Neumann H P, Scheremet R, Volk B, Mann W, Gilsbach J, Laszig R. Deafness due to bilateral endolymphatic sac tumours in a case of von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry. 1996; 61 318-320
- 18 Panchwagh J, Goel A, Shenoy A. Bilateral endolymphatic papillary carcinoma. Br J Neurosurg. 1999; 13 79-81
- 19 Neumann H P, Wiestler O D. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet. 1991; 337 1052-1054
- 20 Neumann H P, Berger D P, Sigmund G, Blum U, Schmidt D, Parmer R J, Volk B, Kirste G. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med. 1993; 329 1531-1538
- 21 Neumann H PH. Pheochromocytomas multiple endocrine neoplasia type 2 and von Hippel-Lindau disease. N Engl J Med. 1994; 330 1091-1092
- 22 Neumann H PH, Eng C, Mulligan L M, Glavac D, Ponder B, Crossey P, Maher E, Brauch H. Consequences of direct genetic testing for germline mutations in the clinical management of families with mutiple endocrine neoplasia type II. JAMA. 1995; 274 1149-1151
- 23 Maher E R, Kaelin W G . Von Hippel-Lindau disease. Medicine (Baltimore). 1997; 76 381-391
- 24 Seizinger B R, Rouleau G A, Ozelius L J, Lane A H, Farmer G E, Lamiell J M, Haines J, Yuen J WM, Collins D, Majoor-Krakauer D, Bonner T, Mathew C, Rubenstein A, Halperin J, McConkie-Rosell A, Green J S, Trofatter J A, Ponder B A, Eierman L, Bowmer M I, Schimke R, Oostra B, Aronin N, Smith D I, Drabkin H, Waziri M H, Hobbs W J, Martuza R L, Conneally P M, Hsia Y E, Gusella J F. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature. 1988; 332 268-269
- 25 Latif F, Tory K, Gnarra J, Yao M, Duh F M, Orcutt M L, Stackouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei M H, Chen F, Glenn G, Choyke P, Walther M M, Weng Y, Duan D R, Dean A, Glavac D, Richards F M, Crossey P A, Ferguson-Smith M A, Le P aslier, Chumakov I, Cohen D, Chinault C A, Maher E. R, Linehan WM, Zbar B. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993; 260 1317-132
- 26 Kuzmin I, Duh F M, Latif F, Geil L, Zbar B, Lerman M I. Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene. Oncogene. 1995; 10 2185-2194
- 27 Blamires T I, Friedman I, Moffat D A. Von Hippel-Lindau disease associated with an invasive choroid plexus tumour presenting as a middle ear mass. J Laryngol Otol. 1992; 106 429-435
- 28 Megerian C A, McKenna M J, Nuss R C, Maniglia A J, Ojemann R G, Pilch B Z, Nadol J B. Endolymphatic sac tumours’ histopathologic confirmation, clinical characterization, and implication in von Hippel-Lindau disease. Laryngoscope. 1995; 105 801-808
- 29 Manski T J, Heffner D K, Glenn G M, Patronas N J, Pikus A T, Katz D. et al . Endolymphatic sac tumours. A source morbid hearing loss in von Hippel-Lindau disease. J Am Med Assoc. 1997; 277 1461-1466
- 30 Tibbs R E , Bowles A P , Raila F A, Fratkin J D, Hutchins J B. Should endolymphatic sac tumors be considered part of the von Hippel-Lindau complex? Pathology case report. Neurosurgery. 1997; 40 848-855
- 31 Vortmeyer A O, Choo D, Pack S D, Oldfield E, Zhuang Z. Von Hippel-Lindau disease gene alterations associated with endolymphatic sac tumor. J Natl Cancer Inst. 1997; 89 970-972
- 32 Megerian C A, Haynes D S, Poe D S, Choo D I, Keriakas T J, Glasscock M E . Hearing preservation surgery for small endolymphatic sac tumors in patients with von Hippel-Lindau syndrome. Otol Neurotol.. 2002; 23 378-387
- 33 Gilsbach J M. Hemangioblastomas of the spinal cord and the brainstem: diagnostic and therapeutic features. Neurosurg Rev. 1996; 19 147-151
- 34 Fill W L, Lamiell J M, Polk N O. The radiographic manifestations of von Hippel-Lindau disease. Radiology. 1979; 133 289-295
- 35 Filling-Katz M R, Choyke P L, Patronas N J, Gorin M B, Barba D, Chang R. et al . Radiologic screening for von Hippel-Lindau disease: the role of Gd-DTPA enhanced MR imaging of the CNS. J Comput Assist Tomogr. 1989; 13 743-755
- 36 Choyke P L, Glenn G M, Walther M M, Patronas N J, Linehan W M, Zbar B. Von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology. 1995; 194 629-642
- 37 Luff D A, Simmons M, Malik T, Ramsden R T, Reid H. Endolymphatic sac tumours. J Laryngol Otol. 2002; 116 398-401
- 38 Trietel L. Über das Carcinom des Ohres. Z Ohrenheilk. 1898; 33 152-164
- 39 Hyams V J, Michaels L. Benign adenomatous neoplasm (adenoma) of the middle ear. Clin Otolaryngol. 1976; 1 17-26
- 40 Von Hippel E. Uber eine sehr seltene Erkrankung der Netzhaut. von Graefes Arch Ophth. 1904; 59 83-106
- 41 Lindau A. Studien über Kleinhirnzysten. Bau, Pathogenese und Beziehungen zur Angiomatosis retinae. Acta Path Microbiol Scand. 1926; Suppl 1 1-128
- 42 Palmer J M, Coker N J, Harper R L. Papillary adenoma of the temporal bone in von Hippel-Lindau disease. Otolaryngol Head Neck Surg. 1989; 100 64-68
- 43 Thomas C B, Kveton J F, Poe D S, Zamani A, Tarlov E C. Aggressive papillary tumour of temporal bone in von Hippel-Lindau disease. Surg Pathol. 1993; 5 63-71
- 44 Kawahara N, Kume H, Ueki K, Mishima K, Sasaki T, Kirino T. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease. Neurology. 1999; 53 208-210
- 45 Glavac D, Neumann H P, Wittke C, Jaenig H, Masek O, Streicher T, Pausch F, Engelhardt D, Plate K H, Hofler H, Chen F, Zbar B, Brauch H. Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe. Hum Genet. 1996; 98 271-280
- 46 Lee K R, Wulfsberg E, Kepes J J. Some important radiological aspects of the kidney in Hippel-Lindau syndrome: the value of prospective study in an affected family. Radiology. 1977; 122 649-653
- 47 Herman J G, Latif F, Weng Y, Lerman M I, Zbar B, Liu S, Samid D, Duan D R, Gnarra J R, Linehan W M, Baylin S B. Silencing of the VHL tumor-suppressor gene by DANN methylation in renal cell carcinoma. Proc Natl Acad Sci USA. 1995; 91 9700-9704
- 48 Iwai K, Yamanaka K, Kamura T, Minato N, Conaway R C, Conaway J W, Klausner R D, Pause A. Identification of the von Hippel-Lindau tumor suppressor protein as part of an active E3 ubiquitin ligase complex. Proc Natl Acad Sci USA. 1999; 96 12 436-12 441
- 49 Bradley J F, Collins D L, Schimke N R, Parrott H N, Rothberg P. Two distinct phenotypes caused by two different missense mutations in the same codon of the VHL gene. Am J Med Genet. 1999; 87 163-167
- 50 Hasse C. Bemerkungen über die Lymphbahnen des inneren Ohres. Arch Ohrenheilk (Leipzig). 1881; 17 188-194
- 51 Heffner D K. Are papillary adenomas endolymphatic sac tumors?. Ann Otol Rhinol Laryngol. 1996; 105 251-252
- 52 Ahuja A, Gibbons K J. Endovascular therapy of central nervous system tumors. Neurosurg Clin N Am. 1994; 5 541-554
- 53 Horton J A, Eelkema E, Albright A L. Preoperative embolization of a hemangioblastoma. AJNR Am J Neuroradiol. 1989; 10 203
- 54 Eskridge J M, McAuliffe W, Harris B, Kim D K, Scott J, Winn H R. Preoperative endovascular embolization of craniospinal hemangioblastomas. AJNR Am J Neuroradiol. 1996; 17 525-531
- 55 Tampieri D, Leblanc R, TerBrugge K. Preoperative embolization of brain and spinal hemangioblastomas. Neurosurgery. 1993; 33 502-505
- 56 Vazquez-Anon V, Botella C, Beltran A, Solera M, Piquer J. Preoperative embolization of solid cervicomedullary junction hemangioblastomas: report of two cases. Neuroradiology. 1997; 39 86-89
- 57 Page K A, Wayson K, Steinberg G K, Adler J R . Stereotaxic radiosurgical ablation: an alternative treatment for recurrent and multifocal hemangioblastomas. A report of four cases. Surg Neurol. 1993; 40 424-428
- 58 Chandler H C , Friedman W A. Radiosurgical treatment of a hemangioblastoma: case report. Neurosurgery. 1994; 34 353-355
- 59 Chang S D, Meisel J A, Hancock S L, Martin D P, McManus M, Adler J R . Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery. Neurosurgery. 1998; 43 28-35
- 60 Chakraborti P R, Chakrabarti K B, Doughty D, Plowman P N. Stereotactic multiple arc radiotherapy. IV-Haemangioblastoma. Br J Neurosurg. 1997; 11 110-115
- 61 Patrice S J, Sneed P K, Flickinger J C, Shrieve D C, Pollock B E, Alexander E, Larson D A, Kondziolka D S, Gutin P H, Wara W M, McDermott M W, Lunsford L D, Loeffler J S. Radiosurgery for hemangioblastoma: results of a multiinstitutional experience. Int J Radiat Oncol Biol Phys. 1996; 35 493-499
- 62 Pan L, Wang E M, Wang B J, Zhou L F, Zhang N, Cai P W, Da JZ. Gamma knife radiosurgery for hemangioblastomas. Stereotact Funct Neurosurg. 1998; 70 (Suppl 1) 179-186
- 63 Neumann H P. Prognosis of von Hippel-Lindau syndrome. Vasa. 1987; 16 309-311
Priv.-Doz. Dr. med. Jörg Schipper
Universitätsklinik für Hals-, Nasen- und Ohrenheilkunde und Poliklinik · Universitätsklinikum Freiburg
Killianstraße 5 · 79106 Freiburg
Email: schipper@hno.ukl.uni-freiburg.de